Rephonic
Artwork for BiotechTV

BiotechTV - News

BiotechTV
Orexin
FDA
Narcolepsy
Alkermes
Takeda
Biogen
Alnylam
Biotechnology
Cedar
Biotech Sector
Pfizer
Xenon
Stoke
China
Clinical Trials
RNA Interference
AI In Biotech
Duchenne Muscular Dystrophy
Axsome Therapeutics
Peanut Allergy

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

PublishesDailyEpisodes280Founded9 months ago
Number of ListenersCategories
ScienceLife Sciences

Listen to this Podcast

Artwork for BiotechTV

Latest Episodes

CEO Robert Jacks describes the history of learning about how Sparrow's asset lowered cortisol in Cushing's syndrome, and new data suggesting that doing so could be beneficial for treatment-resistant T2D patients.

CEO Hugo Fry describes the scientific idea behind antigenic tolerization, and discusses Topas' recent PoC data that was presented at Digestive Disease Week.

He explains the story of this enzyme and the biology of how CTPS1 and CTPS2 interact. Step is in the clinic in lymphoma and solid tumors, and recently raised a €38 series C.

CEO Jordi Fàbrega and CFO Josep Prous discusses the asset, CTH120, which is a NCE and proprietary to Connecta.

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Mathai Mammen
CEO of Parabilis Medicines and former head of R&D at Johnson & Johnson
Parabilis Medicines
Episode: Mathai Mammen recaps the first clinical data Parabilis Medicines reported on its beta-catenin program earlier this month at EMSO and AACR-NCI-EORTC 2025. Plus, degraders for prostate cancer, and more.
Benny Sorensen
CEO of Hemab Therapeutics
Hemab Therapeutics
Episode: Hemab Therapeutics, a company specializing in developing treatments for bleeding disorders, announced a $157 million series C raise today. CEO Benny Sorensen describes the work and unmet need.
Oz Azam
President and CEO of Cue Biopharma
Cue Biopharma
Episode: Biotech veteran Oz Azam has become the CEO of Cue Biopharma. He walks us through the science behind the company's new focus in autoimmune that has him excited about the opportunity
Ros Deegan
Chief Executive of OMass Therapeutics
OMass Therapeutics
Episode: Oxford, UK based OMass Therapeutics, experts in the use of mass spectrometry in drug development, recently landed a $20M up front licensing deal with Roche on one of its preclinical candidates for IBF
Ben Zeskind
Co-founder and CEO of Immuneering.
Immuneering
Episode: Immuneering's CEO walks us through the company's MEK data in pancreatic cancer, and explains the science behind 'deep cyclic inhibition'
Rafiq Hasan
CEO of Complement Therapeutics, physician with experience in clinical development and pharmaceuticals.
Complement Therapeutics
Episode: Complement Therapeutics received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye
Nabanita Nawar
Co-founder and CEO of HDAX Therapeutics
HDAX Therapeutics
Episode: Align Summit: Toronto based HDAX Therapeutics believes there are many indications to tackle with its dual binding approach to HDAC6
Aaron Edwards
Co-founder and CEO of KiraGen Bio
KiraGen Bio
Episode: Align Summit: Allston based KiraGen Bio is aiming to program CAR-T cells to tune out the suppressive nature of the tumor micro environment. The first program will be for GBM.
Ashoka Rejendra
Founder and CEO of Orchestra Bio
Orchestra Bio
Episode: After exiting stealth with $20 million two weeks ago, Orchestra Bio is out to help science entrepreneurs handle the dollars and cents management and long term planning that business requires

Hosts

Ryan Flynn
Host who introduces and talks with guests about various biotech developments and industry insights.
Brad
Host who introduces and engages in discussions with guests about biotechnology news and trends.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Sonoma Biotherapeutics announced early clinical data today in a late-breaker at #ACR25 for its CAR-Treg to treat rheumatoid arthritis. Co-Founders Jeff Bluestone and Fred Ramsdell walk us through it.
Q: What are the next steps for your trial?
We are starting to dose patients in our highest cell numbers cohort and are designing the phase two trial.
Mathai Mammen recaps the first clinical data Parabilis Medicines reported on its beta-catenin program earlier this month at EMSO and AACR-NCI-EORTC 2025. Plus, degraders for prostate cancer, and more.
Q: Would that potentially be in combination with AR deprivation therapies?
It can be. Typically we will demonstrate single agent activity and then move in combination with other agents.
Mathai Mammen recaps the first clinical data Parabilis Medicines reported on its beta-catenin program earlier this month at EMSO and AACR-NCI-EORTC 2025. Plus, degraders for prostate cancer, and more.
Q: Do you feel like you understand the dosing, like go forward dosing and all of that at this point?
We have clearly identified the small dose range that we will use in a late phase registrational study.
Biotech veteran Oz Azam has become the CEO of Cue Biopharma. He walks us through the science behind the company's new focus in autoimmune that has him excited about the opportunity
Q: What about the company attracted you to it?
Cue has an amazing reputation in the Boston ecosystem, with great leadership and transformative science that inspired my passion to join.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BiotechTV

What is BiotechTV about and what kind of topics does it cover?

The content primarily revolves around recent developments in the biotechnology sector, emphasizing breakthroughs in medical research, treatments, and the implications of regulatory changes. Episodes often feature in-depth discussions with industry leaders, including CEOs and innovators from biotech companies, who provide insights into emerging technologies, clinical trials, and market dynamics. The focus on integrating AI into healthcare and the exploration of novel therapeutic strategies illustrate the podcast's commitment to shedding light on critical advancements impacting public health and patient care. This highlights their role not just as an information conduit but as a platform fostering dialogue on pressing issues within the life s... more

Where can I find podcast stats for BiotechTV?

Rephonic provides a wide range of podcast stats for BiotechTV. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BiotechTV and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BiotechTV get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BiotechTV, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BiotechTV?

Rephonic provides comprehensive predictive audience data for BiotechTV, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BiotechTV have?

To see how many followers or subscribers BiotechTV has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BiotechTV?

These podcasts share a similar audience with BiotechTV:

1. Biotech Hangout
2. BioCentury This Week
3. The Long Run with Luke Timmerman
4. The Readout Loud
5. BioVenture VoiCes with Chris Garabedian

How many episodes of BiotechTV are there?

BiotechTV launched 9 months ago and published 280 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BiotechTV?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BiotechTV?

Rephonic pulls ratings and reviews for BiotechTV from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BiotechTV?

Rephonic provides full transcripts for episodes of BiotechTV. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BiotechTV?

Recent guests on BiotechTV include:

1. Mathai Mammen
2. Benny Sorensen
3. Oz Azam
4. Ros Deegan
5. Ben Zeskind
6. Rafiq Hasan
7. Nabanita Nawar
8. Aaron Edwards

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days